摘要
背景:脂质体是具有包埋在脂质双层内的水性核心的囊泡载体。由于生物相容性和生物可降解性以及在脂质双分子层的表面和脂质组成的表面改性灵活性以及脂双层的脂质组成,所以这些是选择的载体。 目的:使用被动和主动靶向方法治疗癌症的脂质体已被报道很好,但肿瘤微环境仍然是安全和有效递送抗癌药物的最大障碍。为了克服这个问题,刺激反应型智能脂质体作为内部触发器,磁场,超声波和氧化还原电位等作为外部指导,以增强反应的pH值,温度和酶等反应性肿瘤环境开创先河,药物输送到肿瘤。 结论:本综述主要集中在所有这些刺激响应方法,即利用脂质体的制造潜力与各种配体,接头和聚乙二醇化等相结合。参与癌症靶向方法的科学家可以从脂质体纳米载体的这些知识丰富的组合中获益良多。
关键词: 刺激敏感,脂质体,热敏感,pH敏感,超声波敏感,智能输送。
图形摘要
Current Drug Targets
Title:Stimuli-responsive Smart Liposomes in Cancer Targeting
Volume: 19 Issue: 3
关键词: 刺激敏感,脂质体,热敏感,pH敏感,超声波敏感,智能输送。
摘要: Background: Liposomes are vesicular carriers which possess aqueous core entrapped within the lipid bilayer. These are carriers of choice because of biocompatible and biodegradable features in addition to flexibility of surface modifications at surface and lipid compositions of lipid bilayers.
Objective: Liposomes have been reported well for cancer treatment using both passive and active targeting approaches however tumor microenvironment is still the biggest hurdle for safe and effective delivery of anticancer agents. To overcome this problem, stimuli-responsive smart liposomes have emerged as promising cargoes pioneered to anomalous tumor milieu in response to pH, temperature, and enzymes etc. as internal triggers, and magnetic field, ultrasound, and redox potential as external guides for enhancement of drug delivery to tumors.
Conclusion: This review focuses on all such stimuli-responsive approaches using fabrication potentiality of liposomes in combination to various ligands, linkers, and PEGylation etc. Scientists engaged in cancer targeting approaches can get benefited greatly with this knowledgeable assemblage of advances in liposomal nanovectors.
Export Options
About this article
Cite this article as:
Stimuli-responsive Smart Liposomes in Cancer Targeting, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160208144143
DOI https://dx.doi.org/10.2174/1389450117666160208144143 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Antihistamine Drugs in Allergic Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design The Challenge of Exploiting ABCG2 in the Clinic
Current Pharmaceutical Biotechnology HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets Cellular Uptake of Cell-Penetrating Peptides
Drug Design Reviews - Online (Discontinued) Tumor Stroma Manipulation By MSC
Current Drug Targets CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Dynamics of CD86 Expression on Allergic Inflammation - New Insights
Recent Patents on Inflammation & Allergy Drug Discovery Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Inflammation & Allergy - Drug Targets (Discontinued) Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Ex Vivo Gene Therapy and Vision
Current Gene Therapy Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge
Current Signal Transduction Therapy Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia
Mini-Reviews in Medicinal Chemistry 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets Targeting the Acute Myeloid Leukemia Stem Cells
Anti-Cancer Agents in Medicinal Chemistry MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets